Arbor Rapha Capital Bioholdings Corp. I (Nasdaq: ARCK) is a blank-check company sponsored by Arbor Rapha Capital that launched its initial public offering in 2021, targeting acquisition opportunities in the life sciences and bioholdings sector. The company filed its S-1 registration statement with the Securities and Exchange Commission on September 14, 2021, positioning itself to pursue a merger or business combination with a healthcare or biotechnology business. ARCK represents part of the broader wave of healthcare-focused SPACs that came to market during the 2021 SPAC boom. Investors and analysts seeking complete deal history, filing timelines, and up-to-date status data on ARCK and hundreds of other SPACs can sign up for full access at SpacDesk.